Cargando…
Profile of BRAFV600E, BRAFK601E, NRAS, HRAS, and KRAS Mutational Status, and Clinicopathological Characteristics of Papillary Thyroid Carcinoma in Indonesian National Referral Hospital
INTRODUCTION: BRAFV600E and RAS mutations are the most common gene mutations in papillary thyroid carcinoma (PTC) that may be correlated with its biological behavior. There are still limited data about BRAFV600E and RAS mutations in Indonesia. This study aims to determine the prevalence of BRAFV600E...
Autores principales: | Harahap, Agnes Stephanie, Subekti, Imam, Panigoro, Sonar Soni, Asmarinah, Lisnawati, Werdhani, Retno Asti, Agustina, Hasrayati, Khoirunnisa, Dina, Mutmainnah, Mutiah, Salinah, Siswoyo, Alvita Dewi, Ham, Maria Francisca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226481/ https://www.ncbi.nlm.nih.gov/pubmed/37255533 http://dx.doi.org/10.2147/TACG.S412364 |
Ejemplares similares
-
Developing Models to Predict BRAFV600E and RAS Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression
por: Harahap, Agnes Stephanie, et al.
Publicado: (2023) -
Sistrunk Procedure on Malignant Thyroglossal Duct Cyst
por: Kartini, Diani, et al.
Publicado: (2020) -
BRAFV600E and KIT immunoexpression in early-stage melanoma
por: Germano, Andressa, et al.
Publicado: (2019) -
Sequence of therapies for advanced BRAFV600E/K melanoma
por: Gonzalez-Cao, Maria, et al.
Publicado: (2023) -
BRAFV600E Negatively Regulates the AKT Pathway in Melanoma Cell Lines
por: Chen, Brenden, et al.
Publicado: (2012)